Instead, in breast cancer cells, PEITC can target breast cancer stem cells through the epigenetic reactivation of cadherin 1, a tumor suppressor gene, by inhibiting DNMT and HDAC activity, thus demethylating its promoter site [136]. This evidence concerns the gene CDH1 and breast carcinoma.